CHAMPIONS ONCOLOGY, INC. Grants Receivable, Current
CHAMPIONS ONCOLOGY, INC. (CSBR) had Grants Receivable, Current of $0 as of 2012-04-30, per its 10-K filed 2012-07-18.
Discontinued › Notes › and Others
us-gaap:GrantsReceivableCurrent · last filed 2013-07-26
- 2012-04-30: Grants Receivable, Current $0.00.
- 2012-02-13: Grants Receivable, Current $500.00K.
- 2012-01-31: Grants Receivable, Current $505.00K.
- 2011-10-31: Grants Receivable, Current $517.00K.
| Period end | Grants Receivable, Current |
|---|---|
| 2012-04-30 | $0.00 10-K · filed 2012-07-18 |
| 2012-02-13 | $500.00K 10-K · filed 2013-07-26 |
| 2012-01-31 | $505.00K 10-Q · filed 2012-03-14 |
| 2011-10-31 | $517.00K 10-Q · filed 2011-12-14 |
| 2011-07-31 | $504.00K 10-Q · filed 2011-09-13 |
| 2011-04-30 | $517.00K 10-K · filed 2012-07-18 |
| 2010-12-31 | $1.00M 10-Q · filed 2012-12-13 |
| 2010-11-30 | $1.00M 10-K · filed 2013-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |